-
Something wrong with this record ?
Sequential Injection Analysis for Automation and Evaluation of Drug Liberation Profiles: Clotrimazole Liberation Monitoring
H. Sklenářová, M. Beran, L. Novosvětská, D. Šmejkalová, P. Solich
Language English Country Switzerland
Document type Evaluation Study, Journal Article
Grant support
CZ.02.1.01/0.0/0.0/15_003/0000465
Ministerstvo Školství, Mládeže a Tělovýchovy
SVV 260 548
Univerzita Karlova v Praze
21930006
International Visegrad Fund
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Antifungal Agents analysis MeSH
- Kinetics MeSH
- Clotrimazole analysis MeSH
- Automation, Laboratory methods MeSH
- Skin Cream MeSH
- Drug Compounding MeSH
- Flow Injection Analysis methods MeSH
- Drug Liberation MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
A fully automated sequential injection system was tested in terms of its application in liberation testing, and capabilities and limitations were discussed for clotrimazole liberation from three semisolid formulations. An evaluation based on kinetic profiles obtained in short and longer sampling intervals and steady-state flux values were applied as traditional methods. The obtained clotrimazole liberation profile was faster in the case of Delcore and slower for Clotrimazol AL and Canesten cream commercial formulations. The steady-state flux values for the tested formulations were 52 µg cm-2 h-1 for Canesten, 35 µg cm-2 h-1 for Clotrimazol AL, and 7.2 µg cm-2 h-1 for Delcore measured in 4 min sampling intervals. A simplified approach for the evaluation of the initial rate based on the gradient between the second and third sampling points was used for the first time and was found to correspond well with the results of the conventional methods. A comparison based on the ratio of the steady-state flux and the initial rate values for Canesten and Clotrimazol AL proved the similarity of the obtained results. The proposed alternative was successfully implemented for the comparison of short-term kinetic profiles. Consequently, a faster and simpler approach for dissolution/liberation testing can be used.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003740
- 003
- CZ-PrNML
- 005
- 20220127145924.0
- 007
- ta
- 008
- 220113s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules26185538 $2 doi
- 035 __
- $a (PubMed)34577009
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sklenářová, Hana $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 245 10
- $a Sequential Injection Analysis for Automation and Evaluation of Drug Liberation Profiles: Clotrimazole Liberation Monitoring / $c H. Sklenářová, M. Beran, L. Novosvětská, D. Šmejkalová, P. Solich
- 520 9_
- $a A fully automated sequential injection system was tested in terms of its application in liberation testing, and capabilities and limitations were discussed for clotrimazole liberation from three semisolid formulations. An evaluation based on kinetic profiles obtained in short and longer sampling intervals and steady-state flux values were applied as traditional methods. The obtained clotrimazole liberation profile was faster in the case of Delcore and slower for Clotrimazol AL and Canesten cream commercial formulations. The steady-state flux values for the tested formulations were 52 µg cm-2 h-1 for Canesten, 35 µg cm-2 h-1 for Clotrimazol AL, and 7.2 µg cm-2 h-1 for Delcore measured in 4 min sampling intervals. A simplified approach for the evaluation of the initial rate based on the gradient between the second and third sampling points was used for the first time and was found to correspond well with the results of the conventional methods. A comparison based on the ratio of the steady-state flux and the initial rate values for Canesten and Clotrimazol AL proved the similarity of the obtained results. The proposed alternative was successfully implemented for the comparison of short-term kinetic profiles. Consequently, a faster and simpler approach for dissolution/liberation testing can be used.
- 650 _2
- $a antifungální látky $x analýza $7 D000935
- 650 _2
- $a laboratorní automatizace $x metody $7 D057205
- 650 _2
- $a klotrimazol $x analýza $7 D003022
- 650 _2
- $a příprava léků $7 D004339
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a průtoková injekční analýza $x metody $7 D017022
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a pleťový krém $7 D063465
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Beran, Marek $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Novosvětská, Lucie $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Šmejkalová, Daniela $u Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic
- 700 1_
- $a Solich, Petr $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 18 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34577009 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145921 $b ABA008
- 999 __
- $a ok $b bmc $g 1751250 $s 1154889
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 18 $e 20210912 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a CZ.02.1.01/0.0/0.0/15_003/0000465 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a SVV 260 548 $p Univerzita Karlova v Praze
- GRA __
- $a 21930006 $p International Visegrad Fund
- LZP __
- $a Pubmed-20220113